AMZN
Amazon.com, Inc.
AMZN has the edge over PRKS overall, supported by stronger valuation and stronger modeled upside.
PRKS
United Parks & Resorts Inc.
PRKS trails on the overall score without a compensating advantage in the available component scores.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
PRKS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Weak |
PRKS's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is weak.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over PRKS in the historical PE scenario, which offers more potential upside but is not a forecast.
PRKS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 11x | $40.16 | — |
| Cheap | 12x | $32.45 | -19% |
| Fair | 14x | $37.08 | -7.7% |
| Current | 15x | $40.16 | — |
| Expensive | 18x | $47.84 | +19% |
Historical ranges are pointers, not guarantees.
PRKS's PE is in its expensive range at 15x. On analysts' estimates for next year's earnings, today's price would be 11x, in its cheap range.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
PRKS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Stable | |
| Stable | |
| Weakening | |
| Limited | |
| Low |
Analysts expect PRKS's profitability to weaken, with its earnings and revenue holding steady. However, they disagree widely on these estimates.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over PRKS on earnings, with more consistent year-over-year improvement.
PRKS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.65 | +36% |
| Q3 2026 | $2.68 | -16% |
| Q2 2026 | $2.55 | -30% |
| Q1 2026 | $2.66 | -28% |
| Q4 2025 | $3.06 | -19% |
| Q3 2025 | $3.19 | -20% |
| Q2 2025 | $3.66 | -4.4% |
| Q1 2025 | $3.67 | -1.3% |
| Q4 2024 | $3.79 | +4.4% |
PRKS's earnings per share have fallen from their peak: $2.68 over the past year, against $4.41 in late 2022.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over PRKS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
PRKS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $506.5M | -1.1% |
| Q2 2026 | $483.3M | -1.4% |
| Q1 2026 | $278.3M | -3% |
| Q4 2025 | $373.5M | -2.8% |
| Q3 2025 | $511.9M | -6.2% |
| Q2 2025 | $490.2M | -1.5% |
| Q1 2025 | $286.9M | -3.5% |
| Q4 2024 | $384.4M | -1.2% |
PRKS's revenue grew through 2022 and has held roughly level since: $506M last quarter, down 1.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 28% | -1.9 points |
| Q2 2026 | 24% | -4.4 points |
| Q1 2026 | -3% | -8.9 points |
| Q4 2025 | 15% | -4.6 points |
| Q3 2025 | 30% | -7.2 points |
| Q2 2025 | 29% | -4.4 points |
| Q1 2025 | 5.9% | -1.6 points |
| Q4 2024 | 20% | -3.2 points |
PRKS has the edge over AMZN on profitability, with a higher operating margin.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
PRKS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $23.5M | -38% |
| Q2 2026 | $101.5M | -21% |
| Q1 2026 | -$2.8M | +$28.4M |
| Q4 2025 | $28.1M | -67% |
| Q3 2025 | $38M | -44% |
| Q2 2025 | $127.6M | +36% |
| Q1 2025 | -$31.2M | -$15.3M |
| Q4 2024 | $86.2M | +141% |
PRKS has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
PRKS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.5% | -1.2M shares |
| 1 year | -17% | -9.5M shares |
| 3 years | -29% | -18.4M shares |
| 5 years | -43% | -34M shares |
| Available history | -43% | -35.1M shares |
PRKS has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $126.4M |
| Q1 2026 | $93.8M |
| Q4 2025 | $144.1M |
| Q3 2025 | $7.1M |
| Q2 2025 | $4.6M |
| Q1 2025 | $4.6M |
| Q4 2024 | $37.7M |
PRKS spent $364M buying back its own shares over the past year, about seven times what it spent the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over PRKS on leverage, with a lower net debt burden relative to earnings.
PRKS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.6x | High |
| Q2 2026 | 4.5x | High |
| Q1 2026 | 4.3x | High |
| Q4 2025 | 4.0x | Elevated |
| Q3 2025 | 3.7x | Elevated |
| Q2 2025 | 3.4x | Elevated |
| Q1 2025 | 3.5x | Elevated |
| Q4 2024 | 3.4x | Elevated |
PRKS's net debt is about 4.6 years of its operating earnings (EBITDA), up from 3.7 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
PRKS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 39.7 | Neutral |
PRKS's weekly RSI is 54 (neutral) and its Stochastic is 40 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
PRKS PE vs Consumer Cyclical Sector
| Metric | PRKS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 18x | 17% below |
| PE % | 73 | 47 | 26 pts above |
PRKS has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over PRKS on trend strength, trading above more of its moving averages.
PRKS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $34.0 | 18% above |
| 20 week MA | $39.5 | 1.6% above |
| 50 week MA | $37.9 | 5.9% above |
| 100 week MA | $43.1 | 6.8% below |
| 200 week MA | $48.1 | 16% below |
PRKS has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 16% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over PRKS on returns for 2026, with the stronger performance.
PRKS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $32.2 | $30.6 | -5.2% |
| 2021 | $30.6 | $66.9 | +119% |
| 2022 | $66.9 | $54.3 | -19% |
| 2023 | $54.3 | $52.8 | -2.7% |
| 2024 | $52.8 | $55.4 | +4.9% |
| 2025 | $55.4 | $36.0 | -35% |
| 2026 YTD | $36.0 | $40.2 | +12% |
PRKS has finished lower in four of the last six years. It's up 12% so far in 2026.